Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY Medicare Demonstration Projects

2025 HCPCS code G9088

Oncology - other

2025 HCPCS code G9080

Oncology - Other

2025 HCPCS code G9084

Oncology - other. Current Disease Status of Oncology, Colon Cancer, Limited to Invasive, Adenocarcinoma Predominant, T1-T3, N0, M0, No Evidence of Progression, Recurrence or Metastases.

2025 HCPCS code G9073

Invasive female breast cancer, predominantly adenocarcinoma, Stage IIIA-IIIB (not T3, N1, M0), ER/PR positive, no progression/recurrence/metastasis, not ductal carcinoma in situ.

2025 HCPCS code G9135

Oncology; Disease status; Non-Hodgkin’s lymphoma, any cellular classification; Stage III, IV, not relapsed, not refractory.

2025 HCPCS code G9102

Oncology; disease status; gastric cancer, limited to adenocarcinoma, clinical or pathologic M0, unresectable with no evidence of disease progression (for use in a Medicare-approved demonstration project).

2025 HCPCS code G9061

Available practice guidelines do not address the patient's specific cancer condition.

2025 HCPCS code G9107

Oncology - other

2025 HCPCS code G9109

Disease status of head and neck cancer, limited to cancers of the oral cavity, pharynx, and larynx with squamous cell as the predominant cell type, showing no disease progression.

2025 HCPCS code G9094

Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a Medicare-approved demonstration project).

2025 HCPCS code G9060

Oncology - Management Differs From Practice Guidelines.

2025 HCPCS code G9016

Smoking cessation counseling, individual, per session (6-10 minutes), used in Medicare demonstration projects.

2025 HCPCS code G9092

Oncology - Rectal Cancer, Limited to Invasive, Predominantly Adenocarcinoma, T1-T3, N1-N2, M0, Pre-Neoadjuvant Therapy, No Evidence of Progression/Recurrence/Metastases

2025 HCPCS code G9131

Oncology - Other

2025 HCPCS code G9089

Oncology - disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or extent not listed in patient record.

2025 HCPCS code G9079

Oncology - Prostate cancer, limited to adenocarcinoma, T3B to T4, any N, any T, at initial diagnosis was N1, no evidence of disease progression, recurrence, or metastasis, for Medicare demonstration project.

2025 HCPCS code G9101

Provides information on the disease status of gastric adenocarcinoma, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9083

Reports the disease status of a patient's prostate cancer, limited to adenocarcinoma, where the extent of the disease is unknown, staging is in progress, or not listed in the record; used in a Medicare-approved demonstration project.

2025 HCPCS code G9075

Reports information on the disease status of a patient's invasive female breast cancer (adenocarcinoma, M1 stage at diagnosis, metastatic, locally recurrent, or progressive; excludes ductal carcinoma origin).

2025 HCPCS code G9091

Reports information on the disease status of a patient's rectal cancer (predominantly adenocarcinoma, T3N0M0 stage before neoadjuvant therapy) within a specific Medicare demonstration project.

2025 HCPCS code G9050

This HCPCS code reports the primary focus of an evaluation and management (E/M) visit for a cancer patient, including work-up, evaluation, or staging at diagnosis or recurrence.

2025 HCPCS code G9077

Reports information on prostate cancer disease status for a Medicare-approved demonstration project.

2025 HCPCS code G9106

Provides information on the disease status of pancreatic cancer (adenocarcinoma) post-R1 or R2 resection, with no disease progression or metastases; used in a Medicare-approved demonstration project.

2025 HCPCS code G9139

Provides information about chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome or BCR-ABL gene, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9108

Provides information on the disease status of metastatic pancreatic adenocarcinoma with unknown extent of progression; used in a 2006 Medicare demonstration project.

2025 HCPCS code G9058

Reports that patient management differs from practice guidelines due to provider disagreement with recommendations; used in a Medicare demonstration project.

2025 HCPCS code G9138

Provides information on the disease status of non-Hodgkin's lymphoma undergoing evaluation for response to therapy or recurrence, with the current stage unverified.Used as part of a 2006 Medicare demonstration project.

2025 HCPCS code G9013

This HCPCS code reports an end-stage renal disease (ESRD) demonstration project basic bundle level one service.

2025 HCPCS code G9097

This code reports information on the disease status of esophageal cancer (adenocarcinoma or squamous cell carcinoma), used in a 2006 Medicare demonstration project.

2025 HCPCS code G9072

Oncology - other

2025 HCPCS code G9132

Oncology - Other

2025 HCPCS code G9069

Oncology - disease status; small cell lung cancer (limited to small cell and combined small cell/non-small cell); extensive stage at diagnosis, metastatic, locally recurrent, or progressive. For use in a Medicare-approved demonstration project.

2025 HCPCS code G9068

Oncology disease status limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a Medicare-approved demonstration project).

2025 HCPCS code G9134

Non-Hodgkin’s lymphoma, stage I/II, any cell type, not relapsed/recurrent, nonrefractory.

2025 HCPCS code G9130

Oncology - Other

2025 HCPCS code G9129

Oncology - Other (Medicare demonstration project, 2006)

2025 HCPCS code G9128

Multiple Myeloma, Stage IA

2025 HCPCS code G9133

G9133 reports the disease status of hormone-responsive prostate adenocarcinoma with metastases, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9070

Reports information on a patient's small cell lung cancer disease status (extent unknown, staging in progress, or not listed) for a Medicare demonstration project.

2025 HCPCS code G9067

Reports the disease status for non-small cell lung cancer when the extent is unknown, staging is in progress, or not listed; used within a specific Medicare demonstration project.

2025 HCPCS code G9087

Reporting code for a Medicare demonstration project, indicating a patient's colon cancer status (invasive adenocarcinoma, M1 metastasis, progressive disease).

2025 HCPCS code G9086

Reports information on a patient's colon cancer disease status: limited invasive adenocarcinoma (T1-T4, N1-N2, M0), with no evidence of progression, recurrence, or metastasis; used within a specific Medicare demonstration project.

2025 HCPCS code G9066

Reports information on a patient's disease status for non-small cell lung cancer (NSCLC), specifically stages IIIB-IV at diagnosis (metastatic, locally recurrent, or progressive), used within a Medicare demonstration project.

2025 HCPCS code G9100

Provides information about the disease status of gastric adenocarcinoma, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9059

Indicates that a cancer patient's management differs from practice guidelines due to their choice of alternative treatment or no treatment after guideline-consistent treatment was offered.

2025 HCPCS code G9140

Covers a stay of four or more hours in a CMS-approved Frontier Extended Stay Clinic (FESC) for seriously ill patients unable to transfer to an acute care hospital due to extenuating circumstances.

2025 HCPCS code G9055

This HCPCS code reports the primary focus of a cancer patient's visit when another unspecified service is rendered, not listed in other HCPCS codes.It's part of a Medicare demonstration project.

2025 HCPCS code G9113

Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage IA-B (grade 1) without recurrence or progression.

2025 HCPCS code G9056

This HCPCS code reports adherence to practice guidelines for oncology treatment within a specific Medicare demonstration project.

2025 HCPCS code G9117

This HCPCS code reports the disease status of ovarian cancer, specifically epithelial cancer with unknown progression extent, for a Medicare demonstration project (2006).